Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A follow up phase 2 study of the topical formulation of FOL-005 for the treatment of hair loss

Trial Profile

A follow up phase 2 study of the topical formulation of FOL-005 for the treatment of hair loss

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs FOL 005 (Primary)
  • Indications Alopecia
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Follicum AB
  • Most Recent Events

    • 12 Nov 2019 According to an Follicum AB media release, the company intends to submit the application for starting the phase IIa study with the new formulation to the German Federal Institute for Drugs and Medical Devices (BfArM) in November.
    • 12 Nov 2019 According to an Follicum AB media release, the company has signed a collaboration agreement with proDERM for conducting this new clinical trial with a cream-like formulation of FOL-005. This study will be carried out at two clinics in part at Charite University Hospital and at proDERM.
    • 22 Oct 2019 According to a Follicum AB media release, the company announced that if this study continues in accordance with the communicated time plan they expect the top-line data during autumn 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top